-1 Part I Concept of Screening 0

First Page		Document Content
Date: 2006-08-15 04:44:49 Drug discovery Molecular biology Pharmacology Medicinal chemistry Clinical research Drug design High-throughput screening Reverse genetics Mammalian target of rapamycin Biology Pharmaceutical sciences Science		-1 Part I Concept of Screening 0 Add to Reading List Source URL: www.wiley-vch.de Download Document from Source Website File Size: 140,83 KB Share Document on Facebook

	ED/MD ED/MD is one of NBD’s core structure-based drug design technologies. It has been developed in one of the most highly reputed simulation groups in Europe (M. Orozco group, Institute of Research in Biomedicine, Bar DocID: 1vpEv - View Document
	Metody dokowania ligandów Strategie projektowania leków Ligand-based drug design nieznana DocID: 1vpuL - View Document
	Int. J. Computational Biology and Drug Design, Vol. 2, No. 4, 2009 A novel swarm intelligence algorithm for finding DNA motifs Chengwei Lei and Jianhua Ruan* Department of Computer Science, DocID: 1v6tg - View Document
	Send Orders of Reprints at 614 Current Pharmaceutical Design, 2013, 19, Rejuvenating Sirtuins: The Rise of a New Family of Cancer Drug Targets DocID: 1v1vA - View Document
	The University of Siena is pleased to announce the 11th European Workshop in Drug Design and Mu.Ta.Lig. Training School A unique opportunity to learn and share knowledge about computational techniques in an exciting a DocID: 1uQlo - View Document